Financials
- Market Capitalization 448.79 M
- Employee 58
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.93
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2907 | ARVN Arvinas, Inc. - Common Stock | 6.84 USD | -8.19% | -6.43% | -19.43% | -26.45% | 447.24 M USD | ||
| 2912 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.30 USD | -7.14% | -10.96% | -27.37% | +5.69% | 449.14 M USD | ||
| 2922 | NGNE Neurogene Inc. - Common Stock | 21.55 USD | -11.82% | -15.32% | -40.01% | -26.75% | 431.25 M USD | ||
| 2941 | YDES YD Bio Limited - Ordinary Shares | 6.05 USD | -4.42% | -1.63% | +50.87% | -67.12% | 428.28 M USD |